MRK 240726 124.00P (MRK240726P124000) Stock Options, News & Quotes

US OptionsDetailed Quotes

MRK240726P124000

Watchlist

0.74
-0.96-56.47%

15min DelayClose Jul 19 16:00 ET

0.82High0.59Low

Intraday

5D
Daily

News

Merck & Co. Poised for Growth: Strong Q2 Performance and Promising Pipeline Fuel Buy Rating
TipRanks02:47 ET
Kamala Harris' Potential Impact on Health Care Stocks
With President Joe Biden earlier Sunday saying he will end his campaign for re-election and endorsing Vice President Kamala Harris, the focus now turns on her positions on issues.
Seeking Alpha21:02 ET
Here Are Big Pharma's Leading Blockbuster Makers
Seeking AlphaJul 21 07:00 ET
Merck & Co Options Spot-On: On July 19th, 58,773 Contracts Were Traded, With 355.33K Open Interest
On July 19th ET, $Merck & Co(MRK.US)$ had active options trading, with a total trading volume of 58,773 options for the day, of which put options accounted for 9.3% of the total transactions, and
Moomoo NewsJul 19 16:30 ET
Earnings Preview: What to Expect From Merck & Co.'s Report
BarchartJul 19 12:06 ET
BMO Capital Adjusts Price Target on Merck to $150 From $148
Merck (MRK) has an average outperform rating and price target range of $120 to $155, according to analysts polled by Capital IQ.Price: 124.65, Change: +0.40, Percent Change: +0.32
MT NewswiresJul 19 09:18 ET

Comments

Moomoo News Global

Jul 15 07:30

ColumnsTrump's Election Odds Surge After Assassination Attempt: Where Are the Opportunities for Trump Trades?

On Saturday, Donald Trump was shot at a campaign rally in Pennsylvania, which could be a key moment that completely disrupts the US election landscape this year. Following the incident, data from Polymarket shows that Trump's chances of winning the election have skyrocketed to 71%.
After shooting, Bitcoin price briefly surpassed $63,000. $Trump Media & Technology(DJT.US)$ surged over 70% in Mond...

Trump rally incident: How will markets react?

129

Analysts Notebook

Jul 4 08:20

ColumnsWhat Trump 2.0 or Biden 2.0 Could Mean for the Stock Market

President Joe Biden, 81, has stated he remains committed to his re-election campaign despite slipping polling numbers and concerns about his recent public performances.
Reports suggest Biden acknowledged the importance of his upcoming appearances, though the White House denies this claim. His stumbling debate performance and questions about his mental acuity have caused panic within the Democratic Party, leading to speculation about a...

US inflation cools again: Will it pave the way for a rate cut?

ISTJ

Jun 26 09:40

$Merck & Co(MRK.US)$I think it’s just a temp pullback, it just broke the double-bottom line as well as the recent resistence simetanously. The pullback volume is also lower. Expecting new ATH.

Shaaaw

Jun 25 07:07

Here’s why I think that $MRK buys $JANX soon.

$Merck & Co(MRK.US)$ on the prowl for acquisitions up to $15 billion.
$Merck & Co(MRK.US)$ already has an active partnership with $Janux Therapeutics(JANX.US)$ for two TRACtr targets, and CEO Davis has evinced a preference for acquisition of $SPDR S&P Biotech ETF(XBI.US)$ in which $Merck & Co(MRK.US)$ already has a seat at the table.
$Merck & Co(MRK.US)$ acquisition of $HARP earlier this year (for a song) shows their interest in the T Cell engag...

Meltyy

Jun 25 07:02

🔔 FDA PDUFA Update…

🔥 3 PDUFA decisions this week! 👇
📌 This week’s PDUFAs:
$Merck & Co(MRK.US)$ : 🤔
⇨ Patritumab deruxtecan
‣ Non-small cell lung carcinoma
‣ PDUFA date: 6/26/24 (BLA)
$Verona Pharma(VRNA.US)$ : 🤔
⇨ Ensifentrine (Nebulized)
‣ Chronic obstructive pulmonary disease
‣ PDUFA date: 6/26/24 (NDA)
$Genmab(GMAB.US)$ : 🤔
⇨ EPKINLY® (Epcoritamab)
‣ Follicular lymphoma
‣ PDUFA date: 6/28/24 (sBLA)
🗓️ Last week’s PDUFAs:
$Merck & Co(MRK.US)$ : Approved 6/17 🎉
⇨ CAPVAXIVE (V116)
‣ Pneumo...